|The term pharmacovigilance refers to all measures related to the ongoing and systematic monitoring of the safety of medicinal products. On the one hand, pharmacovigilance activities are carried out during the development phase of a new drug within the context of clinical trials, but also following market authorization in order to identify and prevent risks of medicinal products.
Pharmacovigilance measures aim at detecting and evaluating adverse drug reactions and subsequently implementing steps to minimize any risks.
Following market authorization, pharmacovigilance activities are highly important. Drug interactions and rare as well as very rare undesirable side effects are often not observed during the restricted use within a clinical trial. Therefore, ongoing monitoring of a medicinal product is imperative for its overall evaluation and safety.